This document is an official publication from the European Medicines Agency (EMA) detailing the safety recommendations made by its Pharmacovigilance Risk Assessment Committee (PRAC) following its meeting from 27–30 October 2025. It outlines newly identified safety "signals" (potential risks) associated with specific medicines and the regulatory actions required.
This document is the October 2025 newsletter (Volume 19, Issue 10) from the Egyptian Pharmacovigilance Center (EPVC). It is a detailed bulletin focused on drug safety monitoring and public health in Egypt.
This document is the September 2025 newsletter (Volume 19, Issue 9) from the Egyptian Pharmacovigilance Center (EPVC).
The "Think D8" is a mnemonic tool introduced in the WHO AWaRe Antibiotic Book. It is designed to be a mental checklist for healthcare providers to run through before prescribing any antibiotic. Its goal is to ensure a deliberate, rational, and safe approach to antibiotic use, thereby combating antimicrobial resistance (AMR) and protecting patients.
This document is an official communication from the European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC). It summarizes the outcomes of their safety review meeting held from September 29 to October 2, 2025.
This issue of New Zealand's Prescriber Update provides critical safety information and regulatory updates for healthcare professionals, 46(3) September 2025.
RSV Vaccines& Risk of Guillain-Barré Syndrome (GBS), Mesenteric Vascular Occlusion from Oral Contraceptives
Advancing Medication Safety Through Knowledge and Vigilance
